Comparing Breastmilk, Massage, and no Intervention for Pain Management During Vaccination of Term Infants
Launched by UNIVERSITY OF BAMENDA · Mar 13, 2025
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neonates born at or after 37 completed weeks of gestation.
- • Neonates scheduled to receive the DTC-HepB-Hib-1 immunization.
- • Time from last feeding should be greater than or equal to 30 minutes.
- Exclusion Criteria:
- • Term neonates with major congenital abnormalities like limb contractures, limb deformities.
- • Term neonates with any neurological conditions like hydrocephalus, cerebral palsy or birth asphyxia.
- • Infants with acute illness.
- • Infants randomized for no intervention but mothers breastfeed before pain evaluation to calm the babies from crying.
About University Of Bamenda
The University of Bamenda is a distinguished academic institution committed to advancing health research and education in Cameroon and beyond. As a clinical trial sponsor, the university leverages its expertise in various fields, including public health, medicine, and social sciences, to facilitate innovative research that addresses local and global health challenges. With a focus on ethical practices and community engagement, the University of Bamenda fosters collaboration among researchers, healthcare professionals, and stakeholders to enhance the quality of clinical trials and contribute to evidence-based solutions for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bamenda, Northwest Region, Cameroon
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported